Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Schizophrenia

  Free Subscription


29.06.2026

1 Acta Psychiatr Scand
2 Am J Psychiatry
2 Biol Psychiatry
1 Med J Aust
2 Mol Psychiatry
1 Nat Genet
5 Psychiatry Res
2 Psychol Med
3 Schizophr Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Psychiatr Scand

  1. SOMMERHOFF C, Bort M, Prisco M, Paolucci S, et al
    The Prevalence of Obstructive Sleep Apnoea in Schizophrenia, Bipolar Disorder and Major Depressive Disorder: A Systematic Review With Meta-Analysis.
    Acta Psychiatr Scand. 2026 Jun 23. doi: 10.1111/acps.70119.
    PubMed         Abstract available


    Am J Psychiatry

  2. FORSYTH JK, Zhu J, Chavannes AS, Trevorrow ZH, et al
    Association of Fetal Gene Regulatory Gene Deletions With Poor Cognition in Schizophrenia and Community-Based Samples.
    Am J Psychiatry. 2026 Jun 24:appiajp20240779. doi: 10.1176/appi.ajp.20240779.
    PubMed         Abstract available

  3. LAURSEN AF, Bundgaard AF, Lawaetz Daugaard N, Birk M, et al
    Neurocognitive Development in Adolescent Offspring at Familial High Risk of Schizophrenia or Bipolar Disorder and a Population-Based Control Group.
    Am J Psychiatry. 2026 Jun 24:appiajp20250841. doi: 10.1176/appi.ajp.20250841.
    PubMed         Abstract available


    Biol Psychiatry

  4. SVENNINGSSON P
    Ulotaront (SEP363856) Reduces Dopamine Release and Synthesis Capacity in Mice and Patients With Schizophrenia.
    Biol Psychiatry. 2026;100:127-128.
    PubMed        

  5. COHEN AS, Kirkpatrick B, Opler M, Tatsumi K, et al
    A Single, Interpretable Vocal Biomarker for Enriching Antipsychotic Clinical Trials.
    Biol Psychiatry. 2026;100:160-169.
    PubMed         Abstract available


    Med J Aust

  6. MORGAN AJ, Ross AM, McNaught G, Green R, et al
    Stigmatising Attitudes Towards People With Depression, Bipolar Disorder, Borderline Personality, ADHD and Early and Long-Term/Untreated Schizophrenia: Representative Survey of Australian Adults.
    Med J Aust. 2026;224:e70230.
    PubMed         Abstract available


    Mol Psychiatry

  7. CHOPRA S, Worhunsky PD, Naganawa M, Zhang XH, et al
    Widespread synaptic density loss in schizophrenia follows molecular and network architecture.
    Mol Psychiatry. 2026 Jun 25. doi: 10.1038/s41380-026-03717.
    PubMed         Abstract available

  8. JELOVAC A, Braithwaite R
    Re-evaluating response rates, time to reorientation and inadequate seizure duration in magnetic seizure therapy for schizophrenia and major depression.
    Mol Psychiatry. 2026 Jun 22. doi: 10.1038/s41380-026-03699.
    PubMed        


    Nat Genet

  9. ROSSI F, Sportelli L, Kikidis GC, Grassi G, et al
    Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated genes.
    Nat Genet. 2026 Jun 22. doi: 10.1038/s41588-026-02646.
    PubMed         Abstract available


    Psychiatry Res

  10. SOLBERG AC, Ottesen AA, Barrett EA, Mork E, et al
    Characteristics of self-harm in patients with first episode psychosis.
    Psychiatry Res. 2026;364:117278.
    PubMed         Abstract available

  11. MOREJON AJV, Reyes AV, Munoz-Caracuel MA, Vazquez-Morejon R, et al
    Predicting relapse risk from patients' perceptions of family functioning in early psychosis: A three-year longitudinal study.
    Psychiatry Res. 2026;364:117281.
    PubMed         Abstract available

  12. KROKEN RA, Johnsen E, Alisauskiene R, Anda LG, et al
    Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.
    Psychiatry Res. 2026;364:117266.
    PubMed         Abstract available

  13. IFTENI P, Miron AA, Necula R, Dima L, et al
    Patterns of onset and progression of psychoses induced by psychoactive substance use.
    Psychiatry Res. 2026;364:117283.
    PubMed         Abstract available

  14. MIYAKE R, Esaki Y, Taniguchi R, Obayashi K, et al
    Light exposure at night and subjective and objective sleep parameters in patients with schizophrenia: A cross-sectional analysis of the LENS study.
    Psychiatry Res. 2026;364:117302.
    PubMed         Abstract available


    Psychol Med

  15. NAKAMURA H, Kano Y, Sugihara G, Takemura R, et al
    An integrative NLP framework identifies multilevel linguistic phenotypes of schizophrenia across tasks.
    Psychol Med. 2026;56:e193.
    PubMed         Abstract available

  16. LU C, Dong Y, Zhai Z, Gao T, et al
    Predicting functional remission after antipsychotic discontinuation: a real-world study in schizophrenia - ERRATUM.
    Psychol Med. 2026;56:e203.
    PubMed        


    Schizophr Res

  17. WEITTENHILLER LP, Abplanalp SJ, Green MF, Reavis EA, et al
    One social interaction after another: Dynamic modeling of social experience in schizophrenia.
    Schizophr Res. 2026;295:274-281.
    PubMed         Abstract available

  18. PAREDES R, Grigoras V, Ferroni F, Ardizzi M, et al
    Reduced synaptic plasticity and E/I imbalance drive peripersonal space boundaries expansion in schizophrenia.
    Schizophr Res. 2026;295:264-273.
    PubMed         Abstract available

  19. CAVALERI D, Crocamo C, Cucchi G, Bartoli F, et al
    Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysis.
    Schizophr Res. 2026;295:253-263.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum